These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10858337)

  • 1. Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene.
    Margolis PS; Hackbarth CJ; Young DC; Wang W; Chen D; Yuan Z; White R; Trias J
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1825-31. PubMed ID: 10858337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of Streptococcus pneumoniae to deformylase inhibitors is due to mutations in defB.
    Margolis P; Hackbarth C; Lopez S; Maniar M; Wang W; Yuan Z; White R; Trias J
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2432-5. PubMed ID: 11502510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YkrB is the main peptide deformylase in Bacillus subtilis, a eubacterium containing two functional peptide deformylases.
    Haas M; Beyer D; Gahlmann R; Freiberg C
    Microbiology (Reading); 2001 Jul; 147(Pt 7):1783-1791. PubMed ID: 11429456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
    Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
    Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.
    Clements JM; Beckett RP; Brown A; Catlin G; Lobell M; Palan S; Thomas W; Whittaker M; Wood S; Salama S; Baker PJ; Rodgers HF; Barynin V; Rice DW; Hunter MG
    Antimicrob Agents Chemother; 2001 Feb; 45(2):563-70. PubMed ID: 11158755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compensatory mutations in agrC partly restore fitness in vitro to peptide deformylase inhibitor-resistant Staphylococcus aureus.
    Zorzet A; Andersen JM; Nilsson AI; Møller NF; Andersson DI
    J Antimicrob Chemother; 2012 Aug; 67(8):1835-42. PubMed ID: 22577101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementation of an Escherichia coli polypeptide deformylase mutant with a gene from Clostridium acetobutylicum ATCC 824.
    Belouski E; Gui L; Rudolph FB; Bennett GN
    Curr Microbiol; 1998 Apr; 36(4):248-9. PubMed ID: 9504995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcus aureus formyl-methionyl transferase mutants demonstrate reduced virulence factor production and pathogenicity.
    Lewandowski T; Huang J; Fan F; Rogers S; Gentry D; Holland R; Demarsh P; Aubart K; Zalacain M
    Antimicrob Agents Chemother; 2013 Jul; 57(7):2929-36. PubMed ID: 23571548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the Thermus thermophilus locus encoding peptide deformylase and methionyl-tRNA(fMet) formyltransferase.
    Meinnel T; Blanquet S
    J Bacteriol; 1994 Dec; 176(23):7387-90. PubMed ID: 7961514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents.
    Guilloteau JP; Mathieu M; Giglione C; Blanc V; Dupuy A; Chevrier M; Gil P; Famechon A; Meinnel T; Mikol V
    J Mol Biol; 2002 Jul; 320(5):951-62. PubMed ID: 12126617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae.
    Min S; Ingraham K; Huang J; McCloskey L; Rilling S; Windau A; Pizzollo J; Butler D; Aubart K; Miller LA; Zalacain M; Holmes DJ; O'Dwyer K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4644-52. PubMed ID: 26014938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.
    Thorarensen A; Deibel MR; Rohrer DC; Vosters AF; Yem AW; Marshall VD; Lynn JC; Bohanon MJ; Tomich PK; Zurenko GE; Sweeney MT; Jensen RM; Nielsen JW; Seest EP; Dolak LA
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1355-8. PubMed ID: 11378353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation.
    Mazel D; Pochet S; Marlière P
    EMBO J; 1994 Feb; 13(4):914-23. PubMed ID: 8112305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that peptide deformylase and methionyl-tRNA(fMet) formyltransferase are encoded within the same operon in Escherichia coli.
    Meinnel T; Blanquet S
    J Bacteriol; 1993 Dec; 175(23):7737-40. PubMed ID: 8244948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of peptide deformylase from Staphylococcus aureus in complex with actinonin, a naturally occurring antibacterial agent.
    Yoon HJ; Kim HL; Lee SK; Kim HW; Kim HW; Lee JY; Mikami B; Suh SW
    Proteins; 2004 Nov; 57(3):639-42. PubMed ID: 15382235
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of peptide deformylase in protein biosynthesis: a proteomic study.
    Bandow JE; Becher D; Büttner K; Hochgräfe F; Freiberg C; Brötz H; Hecker M
    Proteomics; 2003 Mar; 3(3):299-306. PubMed ID: 12627383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of time-dependent inhibition of polypeptide deformylase by actinonin.
    Van Aller GS; Nandigama R; Petit CM; DeWolf WE; Quinn CJ; Aubart KM; Zalacain M; Christensen SB; Copeland RA; Lai Z
    Biochemistry; 2005 Jan; 44(1):253-60. PubMed ID: 15628866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.
    Lee MD; She Y; Soskis MJ; Borella CP; Gardner JR; Hayes PA; Dy BM; Heaney ML; Philips MR; Bornmann WG; Sirotnak FM; Scheinberg DA
    J Clin Invest; 2004 Oct; 114(8):1107-16. PubMed ID: 15489958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.
    Hoover J; Lewandowski T; Straub RJ; Novick SJ; DeMarsh P; Aubart K; Rittenhouse S; Zalacain M
    Antimicrob Agents Chemother; 2016 Jan; 60(1):180-9. PubMed ID: 26482300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.
    Smith KJ; Petit CM; Aubart K; Smyth M; McManus E; Jones J; Fosberry A; Lewis C; Lonetto M; Christensen SB
    Protein Sci; 2003 Feb; 12(2):349-60. PubMed ID: 12538898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.